Aspira Pathlab, a company in the Healthcare Service Provider industry, reported revenue of ₹6.26 crore and a net loss of ₹1.16 crore for the September 2026 quarter.
Aspira Pathlab (BSE: ASPIRA) closed at ₹131.00 on 20 Nov 2026, up 95.7% over the past year. Its market capitalisation is ₹135 crore.
Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.